Your browser doesn't support javascript.
loading
Prolonged-Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers.
Huppertz, Andrea; Ott, Christian; Bruckner, Thomas; Foerster, Kathrin I; Burhenne, Jürgen; Weiss, Johanna; Zorn, Markus; Haefeli, Walter E; Czock, David.
Afiliação
  • Huppertz A; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
  • Ott C; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
  • Bruckner T; Department of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
  • Foerster KI; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
  • Burhenne J; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
  • Weiss J; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
  • Zorn M; Central Laboratory, University Hospital Heidelberg, Heidelberg, Germany.
  • Haefeli WE; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
  • Czock D; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.
Clin Pharmacol Ther ; 106(6): 1290-1298, 2019 12.
Article em En | MEDLINE | ID: mdl-31152598

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tacrolimo / Voriconazol / Inibidores do Citocromo P-450 CYP3A Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tacrolimo / Voriconazol / Inibidores do Citocromo P-450 CYP3A Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article